These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 10390602

  • 1. Mizoribine and mycophenolate mofetil.
    Ishikawa H.
    Curr Med Chem; 1999 Jul; 6(7):575-97. PubMed ID: 10390602
    [Abstract] [Full Text] [Related]

  • 2. Mycophenolate mofetil for the induction and maintenance treatment of lupus nephritis.
    González-Rivera TC, McCune J.
    Immunotherapy; 2011 Dec; 3(12):1431-40. PubMed ID: 22091679
    [Abstract] [Full Text] [Related]

  • 3. Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF).
    Allison AC, Eugui EM.
    Clin Transplant; 1996 Feb; 10(1 Pt 2):77-84. PubMed ID: 8680053
    [Abstract] [Full Text] [Related]

  • 4. Mizoribine versus mycophenolate mofetil or intravenous cyclophosphamide for induction treatment of active lupus nephritis.
    Feng X, Gu F, Chen W, Liu Y, Wei H, Liu L, Yin S, Da Z, Sun L.
    Chin Med J (Engl); 2014 Feb; 127(21):3718-23. PubMed ID: 25382325
    [Abstract] [Full Text] [Related]

  • 5. Molecular mechanisms of new immunosuppressants.
    Halloran PF.
    Clin Transplant; 1996 Feb; 10(1 Pt 2):118-23. PubMed ID: 8680047
    [Abstract] [Full Text] [Related]

  • 6. Mycophenolate mofetil--clinical and experimental experience.
    Pirsch JD, Sollinger HW.
    Ther Drug Monit; 1996 Aug; 18(4):357-61. PubMed ID: 8857550
    [Abstract] [Full Text] [Related]

  • 7. [Pharmacological profiles of mycophenolate mofetil (CellCept), a new immunosuppressive agent].
    Yashima Y, Ohgane T.
    Nihon Yakurigaku Zasshi; 2001 Feb; 117(2):131-7. PubMed ID: 11233304
    [Abstract] [Full Text] [Related]

  • 8. Comparative efficacy and safety of mizoribine with mycophenolate mofetil for Asian renal transplantation--a meta-analysis.
    Xing S, Yang J, Zhang X, Zhou P.
    Clin Biochem; 2014 May; 47(7-8):663-9. PubMed ID: 24463228
    [Abstract] [Full Text] [Related]

  • 9. Combination effect of mycophenolate mofetil with mizoribine on cell proliferation assays and in a mouse heart transplantation model.
    Shimmura H, Tanabe K, Habiro K, Abe R, Toma H.
    Transplantation; 2006 Jul 27; 82(2):175-9. PubMed ID: 16858279
    [Abstract] [Full Text] [Related]

  • 10. Mycophenolic Acid Derivatives with Immunosuppressive Activity from the Coral-Derived Fungus Penicillium bialowiezense.
    Zhang Q, Yang B, Li F, Liu M, Lin S, Wang J, Xue Y, Zhu H, Sun W, Hu Z, Zhang Y.
    Mar Drugs; 2018 Jul 07; 16(7):. PubMed ID: 29986508
    [Abstract] [Full Text] [Related]

  • 11. Mycophenolate mofetil, an inhibitor of inosine monophosphate dehydrogenase, causes a paradoxical elevation of GTP in erythrocytes of renal transplant patients.
    Goldsmith D, Carrey EA, Edbury S, Smolenski RT, Jagodzinski P, Simmonds HA.
    Clin Sci (Lond); 2004 Jul 07; 107(1):63-8. PubMed ID: 14723604
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Mycophenolate mofetil: An update.
    Villarroel MC, Hidalgo M, Jimeno A.
    Drugs Today (Barc); 2009 Jul 07; 45(7):521-32. PubMed ID: 19834629
    [Abstract] [Full Text] [Related]

  • 14. A review of clinical experience with the novel immunosuppressive drug mycophenolate mofetil in renal transplantation.
    Behrend M.
    Clin Nephrol; 1996 May 07; 45(5):336-41. PubMed ID: 8738667
    [Abstract] [Full Text] [Related]

  • 15. Mycophenolic acid, mycophenolate mofetil, mizoribine, ribavirin, and 7-nitroindole inhibit propagation of Babesia parasites by targeting inosine 5'-monophosphate dehydrogenase.
    Cao S, Aboge GO, Terkawi MA, Zhou M, Kamyingkird K, Moumouni PF, Masatani T, Igarashi I, Nishikawa Y, Suzuki H, Xuan X.
    J Parasitol; 2014 Aug 07; 100(4):522-6. PubMed ID: 24580148
    [Abstract] [Full Text] [Related]

  • 16. [Pharmacology of mycophenolate mofetil: recent data and clinical consequences].
    Thervet E, Anglicheau D, Legendre C.
    Nephrologie; 2001 Aug 07; 22(7):331-7. PubMed ID: 11817210
    [Abstract] [Full Text] [Related]

  • 17. Effects of long-term treatment with mizoribine in patients with proliferative lupus nephritis.
    Yumura W, Suganuma S, Uchida K, Moriyama T, Otsubo S, Takei T, Naito M, Koike M, Nitta K, Nihei H.
    Clin Nephrol; 2005 Jul 07; 64(1):28-34. PubMed ID: 16047642
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Long-term mizoribine intermittent pulse therapy for young patients with flare of lupus nephritis.
    Tanaka H, Tsugawa K, Suzuki K, Nakahata T, Ito E.
    Pediatr Nephrol; 2006 Jul 07; 21(7):962-6. PubMed ID: 16773408
    [Abstract] [Full Text] [Related]

  • 20. Mycophenolate mofetil inhibits rat and human mesangial cell proliferation by guanosine depletion.
    Hauser IA, Renders L, Radeke HH, Sterzel RB, Goppelt-Struebe M.
    Nephrol Dial Transplant; 1999 Jan 07; 14(1):58-63. PubMed ID: 10052478
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.